what happened to critical unmet medical need? the application has been with the EMA for over a year, and CXS pull the plug at the last minute? probably was heading down the same road as the FDA submission in March last year - what else are we to think - and we all know what happened after that.
If approval were likely for T315 indication then the application would surely stand. Don't you think?
anyway....more delays. the only positive in the last few months is Cephalon coming on board.
CXS Price at posting:
46.0¢ Sentiment: None Disclosure: Held
